Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Chronic divalproex sodium use and brain atrophy in Alzheimer disease.

Fleisher AS, Truran D, Mai JT, Langbaum JB, Aisen PS, Cummings JL, Jack CR Jr, Weiner MW, Thomas RG, Schneider LS, Tariot PN; Alzheimer's Disease Cooperative Study.

Neurology. 2011 Sep 27;77(13):1263-71. doi: 10.1212/WNL.0b013e318230a16c. Epub 2011 Sep 14.

2.

Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease.

Tariot PN, Schneider LS, Cummings J, Thomas RG, Raman R, Jakimovich LJ, Loy R, Bartocci B, Fleisher A, Ismail MS, Porsteinsson A, Weiner M, Jack CR Jr, Thal L, Aisen PS; Alzheimer's Disease Cooperative Study Group.

Arch Gen Psychiatry. 2011 Aug;68(8):853-61. doi: 10.1001/archgenpsychiatry.2011.72.

PMID:
21810649
3.

Longitudinal change of biomarkers in cognitive decline.

Lo RY, Hubbard AE, Shaw LM, Trojanowski JQ, Petersen RC, Aisen PS, Weiner MW, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative.

Arch Neurol. 2011 Oct;68(10):1257-66. doi: 10.1001/archneurol.2011.123. Epub 2011 Jun 13.

PMID:
21670386
4.

Travel Assistance in China 1993-1995.

Liu S, Health B, Bureau Q, Zhang Z, Song Y.

J Travel Med. 1997 Jun 1;4(2):107. No abstract available.

PMID:
9815492
5.

A technique to detect reduced mechanical stability of red cell membranes: relevance to elliptocytic disorders.

Mohandas N, Clark MR, Health BP, Rossi M, Wolfe LC, Lux SE, Shohet SB.

Blood. 1982 Apr;59(4):768-74. No abstract available.

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk